Abstract | BACKGROUND:
Nephrogenic systemic fibrosis is a sclerodermalike disease in patients with acute or chronic renal insuffiency related to administration of gadolinium-containing contrast agents. Previous studies have demonstrated clonal T-cell populations in the blood of patients with systemic sclerosis, suggesting that these cells may be involved in the pathogenesis of the disease. Facing the clinical similarities of both diseases, we hypothesized that clonal expansion of T cells could be present in nephrogenic systemic fibrosis as well. OBSERVATIONS:
|
Authors | Alexander Kreuter, Stefan Höxtermann, Thilo Gambichler, Christian Tigges, Stephan A Hahn, Gisela Schieren |
Journal | Archives of dermatology
(Arch Dermatol)
Vol. 145
Issue 10
Pg. 1164-9
(Oct 2009)
ISSN: 1538-3652 [Electronic] United States |
PMID | 19841405
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Biomarkers
- Contrast Media
- Gadolinium
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Autoimmune Diseases
(blood, diagnosis)
- Biomarkers
(metabolism)
- Case-Control Studies
- Contrast Media
(adverse effects)
- Diagnosis, Differential
- Female
- Follow-Up Studies
- Gadolinium
(adverse effects)
- Humans
- Kidney Failure, Chronic
(blood, diagnosis, immunology, therapy)
- Male
- Middle Aged
- Nephrogenic Fibrosing Dermopathy
(blood, diagnosis, immunology, therapy)
- Photopheresis
(methods)
- Probability
- Reference Values
- Renal Dialysis
- Risk Assessment
- Scleroderma, Systemic
(blood, diagnosis, immunology)
- Severity of Illness Index
- T-Lymphocytes
(immunology, metabolism)
- Treatment Outcome
|